Dupixent Keeps Sanofi At Forefront Of European Pharma Growth

Hints At Raised Forecast For Blockbuster

Sanofi_Berlin
A forecast 14% rise in earnings per share in 2021 will put Sanofi among the top European big pharma performers. • Source: Alamy

More from Business

More from Scrip